Upload
mitchell-kennedy
View
222
Download
0
Embed Size (px)
DESCRIPTION
Clinical History Facial tumor with satellite lesions in a 63 year old male with a history of Basal cell carcinoma. Pre-Operative diagnosis “Basal cell carcinoma”. Post-operative diagnosis “Basal cell carcinoma”.
Citation preview
Steven A. Gustafson, D.O. and
Michael C. Awasum M.D.
• Steven A. Gustafson, D.O., Associate professor of Preclinical sciences Collage of Osteopathic Medicine1.
• Michael C. Awasum M.D., Assistant Professor of Pathology, Ponce Health Sciences University2.
• Michael C. Awasum M.D., Attending Pathologist at Southern Pathology Services, Ponce, Puerto Rico2.
William Carey University 1
Southern Pathology 2
Clinical History
• Facial tumor with satellite lesions in a 63 year old male with a history of Basal cell carcinoma.
• Pre-Operative diagnosis “Basal cell carcinoma”.
• Post-operative diagnosis “Basal cell carcinoma”.
Gross specimen
• Scalp tumor, a 8.0 x 4.5 x 0.7 unoriented ellipse of skin with subcutaneous fatty tissue. The epidermal surface shows a 4.5 x 3.0 elevated ulcerated lesion that involves the subcutaneous fatty tissue on serial sectioning.
• Additional satellite lesions consisting of multiple fragments of skin measuring 1.0 x 0.2 x 0.2 cm.
• Immunohistochemical stains were preformed with the following markers: CD3, CD4, CD30, CD45RO, BCL2, Ki57, LCA, MUM-1, CD10, CD20, CD21, CD23, CD25, CD56, CD79A, CK7, CK19, CK20, AE1, AE3, ALK, BCL-6, FOXP1, TIA, TTF1, S-100, P40, GATA-3, NKX3-1, Melan A, D2-40, PAX8, Granzyme.
Immunohistochemical stains performed with the following markers were positive for:CD3, CD4 (strong and focal), CD30, CD45RO, BCL2, Ki67 (60%), LCA, MUM1.
The remaining immunohistochemical stains were negative, notable: ALK, granzyme, and TIA.
H and E Low power
H and E intermediate power
H and E intermediate power 40X
H and E intermediate power 60X
H and E intermediate power 60X
ALK Negative
Take home message
• Anaplastic large cell lymphoma is a distinct category defined by strong expression of CD30.
• Three types have been defined:– Primary systemic ALCL, (ALK+)– Primary systemic ALCL, (ALK-)– Primary cutaneous ALCL
Take home message• Within the primary systemic type several
sub types have been defined:– Giant cell-rich type– Small cell type– Lymphohistiocytic type– Hodgkin-like
• Rare sub forms, sarcomatoid, neutrophil rich, eosinophil rich, signet ring
Take home message
• ALCL has morphologic and clinical features witch overlap with several other hematolymphoid neoplasms most commonly diffuse large B-cell lymphoma, classical Hodgkin disease.
• Primary cutaneous ALCL, overlaps with lymphomatoid papulosis.
Take home message
• It is important to utilize cytogenetic and immunohistochemical markers to sort out these neoplasms some have a poor prognosis, while others are more favorable.
• Thanks to Southern Pathology’s Adalberto Mendoza M.D., Attending Pathologist at Southern Pathology Services, Ponce, Puerto Rico for the initial diagnosis.
• Sothern Pathology, 234-A Sabanet Industrial Park Ponce PR 00716
• William Carey University Collage of Osteopathic Medicine, Hattiesburg, Mississippi 39401.